These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18184072)

  • 1. Body shape and metabolic abnormalities in Thai HIV-infected patients.
    Homsanit M; Nelson KE; Sonjai A; Anekthananon T; Suwanagool S; Cofrancesco J
    AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1314-21. PubMed ID: 18184072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.
    Walmsley S; Cheung AM; Fantus G; Gough K; Smaill F; Azad ; Diong C; Raboud J
    HIV Clin Trials; 2008; 9(5):314-23. PubMed ID: 18977720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.
    Gervasoni C; Ridolfo AL; Trifirò G; Santambrogio S; Norbiato G; Musicco M; Clerici M; Galli M; Moroni M
    AIDS; 1999 Mar; 13(4):465-71. PubMed ID: 10197374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.
    Hammond E; McKinnon E; Nolan D
    Clin Infect Dis; 2010 Sep; 51(5):591-9. PubMed ID: 20645860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.
    Melvin AJ; Lennon S; Mohan KM; Purnell JQ
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1117-23. PubMed ID: 11522181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
    Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
    HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study.
    Blick G; Greiger-Zanlungo P; Gretz S; Han J; Dupree D; Garton T; Yau LH; Wine BC; Pakes GE;
    Int J STD AIDS; 2012 Mar; 23(3):e18-22. PubMed ID: 22581890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.
    Mulligan K; Tai VW; Algren H; Abrams DI; Leiser RJ; Lo JC; Schambelan M
    J Acquir Immune Defic Syndr; 2001 Apr; 26(5):443-8. PubMed ID: 11391163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
    Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
    J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
    Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
    Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
    Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
    Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.
    Mankhatitham W; Luaengniyomkul A; Manosuthi W
    J Med Assoc Thai; 2012 Feb; 95(2):163-9. PubMed ID: 22435244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.